Cardiovascular Advances in Research and Opportunities Legacy Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Apr 15, 2021)
Cardiovascular Advances in Research and Opportunities Legacy Act
This bill expands research on valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart.
The National Institutes of Health must consult with the National Heart, Lung, and Blood Institute to conduct or support research on the disease, including on mitral valve prolapse. This occurs when the valve between the chambers of the left side of the heart seals improperly.
The Centers for Disease Control and Prevention (CDC) must develop best practices to treat valvular heart disease. The CDC may also carry out other projects to increase awareness of and reduce deaths from the disease.
What just happenedApr 15, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1984; text: CR S1985)
Who’s behind it
- Introduced in SenateApr 15, 2021
- Apr 15, 2021IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1984; text: CR S1985)
Health, Education, Labor, and Pensions Committee - Apr 15, 2021IntroReferral10000
Introduced in Senate